Literature DB >> 11313397

Stimulatory effects of B7-related protein-1 on cellular and humoral immune responses in mice.

J Guo1, M Stolina, J V Bready, S Yin, T Horan, S K Yoshinaga, G Senaldi.   

Abstract

Inducible costimulator (ICOS) and B7-related protein-1 (B7RP-1) constitute a receptor-ligand pair involved in T cell costimulation. In this study, the stimulatory effects of B7RP-1 on cellular and humoral immune responses were investigated giving mice a construct with the extracellular domain of murine B7RP-1 fused with human IgG1 Fc (B7RP-1-Fc). B7RP-1-Fc stimulated contact hypersensitivity (CH) given near either the time of sensitization or challenge with oxazolone. When given near challenge time, B7RP-1-Fc stimulated CH more than a construct containing the extracellular domain of murine B7.2 and Fc (B7.2-Fc). B7RP-1-Fc increased the number of cells in lymph nodes draining the skin sensitized with oxazolone, especially activated T cells. B7RP-1-Fc also increased the ability of the cells in these lymph nodes to induce CH when transfused into naive mice. B7RP-1-Fc stimulated the production of anti-keyhole limpet hemocyanin (KLH) Ab, increasing anti-KLH IgG, IgG2a, and IgE, whereas B7.2-Fc did not affect this production. B7RP-1-Fc also increased the number of cells in lymph nodes draining the skin immunized with KLH and their production of IFN-gamma, IL-4, and IL-10 in response to KLH. Finally, B7RP-1-Fc increased the presence of eosinophils in the bronchoalveolar lavage and lungs of mice sensitized and challenged with OVA so to mount an asthmatic reaction. B7RP-1-Fc stimulates both cellular and humoral immune responses in vivo by increasing number and function of T and B cells reacting to Ag exposure.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11313397     DOI: 10.4049/jimmunol.166.9.5578

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  The role of the ICOS-B7h T cell costimulatory pathway in transplantation immunity.

Authors:  Hiroshi Harada; Alan D Salama; Masayuki Sho; Atsushi Izawa; Sigrid E Sandner; Toshiro Ito; Hisaya Akiba; Hideo Yagita; Arlene H Sharpe; Gordon J Freeman; Mohamed H Sayegh
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

2.  CD28 and ICOS play complementary non-overlapping roles in the development of Th2 immunity in vivo.

Authors:  Rebecca A Shilling; Bryan S Clay; Amanda G Tesciuba; Elizabeth L Berry; Tiffany Lu; Tamson V Moore; Hozefa S Bandukwala; Jiankun Tong; Joel V Weinstock; Richard A Flavell; Tom Horan; Steve K Yoshinaga; Andrew A Welcher; Judy L Cannon; Anne I Sperling
Journal:  Cell Immunol       Date:  2009-07-10       Impact factor: 4.868

Review 3.  The role of ICOS and other costimulatory molecules in allergy and asthma.

Authors:  Anthony J Coyle; Jose-Carlos Gutierrez-Ramos
Journal:  Springer Semin Immunopathol       Date:  2004-01-14

4.  In situ expression and significance of B7 costimulatory molecules within tissues of human gastric carcinoma.

Authors:  Xiao-Li Chen; Xu-Dong Cao; An-Jing Kang; Kang-Min Wang; Bao-Shan Su; Yi-Li Wang
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

5.  Inhibitors of mitogen-activated protein kinases differentially regulate costimulated T cell cytokine production and mouse airway eosinophilia.

Authors:  Ligia Chialda; Meixia Zhang; Kay Brune; Andreas Pahl
Journal:  Respir Res       Date:  2005-04-15

6.  Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production.

Authors:  Manabu Kawamoto; Masayoshi Harigai; Masako Hara; Yasushi Kawaguchi; Katsunari Tezuka; Michi Tanaka; Tomoko Sugiura; Yasuhiro Katsumata; Chikako Fukasawa; Hisae Ichida; Satomi Higami; Naoyuki Kamatani
Journal:  Arthritis Res Ther       Date:  2006-03-22       Impact factor: 5.156

Review 7.  Role of Th17 cells in skin inflammation of allergic contact dermatitis.

Authors:  Matthias Peiser
Journal:  Clin Dev Immunol       Date:  2013-08-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.